Healthcare -
Biotechnology - NASDAQ - US
$ 0.6601
-5.47 %
$ 83.3 M
Market Cap
-0.63
P/E
KPTI - STOCK-BASED COMPENSATION
Stock-based Compensation KPTI - Karyopharm Therapeutics Inc.
21.7 M
LAST VALUE
-14.62%
2 YEAR CAGR
4.68%
5 YEAR CAGR
19.09%
10 YEAR CAGR